CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

doi:10.4254/wjh.v6.i7.496

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6717)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

494

WORD

265

HTML

3172

Figures (1-6)

299

Tables (1-1)

267

Sum=4497

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1087

Download

1133

Sum=2220

Jul 27, 2014 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Hepatol. Jul 27, 2014; 6(7): 496-503
Published online Jul 27, 2014. doi: 10.4254/wjh.v6.i7.496

Full Size Figure Download Figure

Figure 6 Fibroscan in controls, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis.

Citation: Cocciolillo S, Parruti G, Marzio L. CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. World J Hepatol 2014; 6(7): 496-503
URL: https://www.wjgnet.com/1948-5182/full/v6/i7/496.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i7.496